Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.

T, Ebata; S, Hirano; M, Konishi; K, Uesaka; Y, Tsuchiya; M, Ohtsuka; Y, Kaneoka; M, Yamamoto; Y, Ambo; Y, Shimizu; F, Ozawa; A, Fukutomi; M, Ando; Y, Nimura; M, Nagino

doi:10.1002/bjs.10776

Public

Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer.

Shared by NobleBlocks on Feb 1, 2018 • 12:00 AM UTC

Authors:

Ebata T

Hirano S

Konishi M

Abstract

<h4>Background</h4>Although some retrospective studies have suggested the value of adjuvant therapy, no recommended standard exists in bile duct cancer. The aim of this study was to test the hypothesis that adjuvant gemcitabine chemotherapy would improve survival probability in resected bile duct ca...

Discussions